Michael Swartzburg serves as Executive at Avalanche Biotechnologies, Inc., where they oversee executive responsibilities. Since joining the company, Michael Swartzburg has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Feb 12, 2016 involved receiving (via award) 36,900 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Feb 12, 2016 | AAVL | $0 | Award | 36,900 | $N/A | Discretionary |
Michael Swartzburg currently holds 82,113 shares of Avalanche Biotechnologies, Inc. (AAVL), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Michael Swartzburg has been a net neutral trader of AAVL stock. They have purchased $0 and sold $0 worth of shares.
Michael Swartzburg's most recent insider trade was on Feb 12, 2016, when they sold 36,900 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted